Sandoz Group AG SIX:SDZ:

  • SANDOZ GROUP AG - FDA ACCEPTS SANDOZ APPLICATIONS FOR PROPOSED IN-HOUSE DEVELOPMENT OF GENERIC TIRZEPATIDE GLP-1S